Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment

By Barragan Patricia   Podzamczer Daniel  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 13, 2008-09 ,pp. : 2363-2375

Informa Healthcare

Access to resources Recommend Favorite

Tipranavir: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients

By de Mendoza Carmen   Morelló Judit   Garcia-Gascó Pilar   Rodríguez-Novoa Sonia   Soriano Vincent  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 6, 2007-04 ,pp. : 839-850

Informa Healthcare

Access to resources Recommend Favorite

Tipranavir: a novel non-peptidic protease inhibitor for the treatment of HIV infection

By Mehandru Saurabh   Markowitz Martin  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1821-1828

Informa Healthcare

Access to resources Recommend Favorite

Darunavir: a nonpeptidic protease inhibitor for antiretroviral-naive and treatment-experienced adults with HIV infection

By Robertson Jaime   Feinberg Judith  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 9, 2012-06 ,pp. : 1363-1375

Informa Healthcare

Access to resources Recommend Favorite

Risk-benefit of HMG-CoA reductase inhibitors in the treatment of HIV protease inhibitor-related hyperlipidaemia

By Penzak Scott R   Chuck Susan K  

Expert Opinion on Drug Safety, Vol. 1, Iss. 1, 2002-05 ,pp. : 5-17

Informa Healthcare

Access to resources Recommend Favorite